Fact CheckerSign in

NCT06848361Active, not recruiting

Helping Adults With Type 2 Diabetes Use Their Health Data for Healthy Diabetes Self-Management

Empowering Adults With Diabetes: Achieving Self-management Success Through Data-Driven Behavior Change, Pilot Randomized Control Trial

Source: ClinicalTrials.gov · Last updated 29 Oct 2026

Brief summary (registry, in English)

Day-to-day self-management by adults with type 2 diabetes, including glucose monitoring, taking medications, and healthy habits, is essential to avoid diabetes complications, yet, despite the rapidly expanding availability of wearable glucose and activity monitors, successful self-management remains challenging for many. This research aims to develop and test an approach to help adults use their personal diabetes information from wearable devices to achieve and sustain health diabetes self-management, which will reduce diabetes complications, and improve health and quality of life for people with type 2 diabetes.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
80 (estimated)
First submitted
21 Feb 2025
Start date
28 Apr 2025
Primary completion date
Dec 2026
Lead sponsor
Ann-Marie Rosland
NCT number
NCT06848361

What you commit to

  • Study type: Interventional
  • Planned participants: 80
  • From 28 Apr 2025 to the primary completion date, Dec 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Has a diagnosis (active or prior) of schizophrenia or other psychotic/delusional disorder

Other illness

  • Has a diagnosis of type 1 diabetes mellitus
  • Has a diagnosis of gestational diabetes without any other diabetes diagnoses
  • Has a life-limiting severe illness (e.g., chronic obstructive pulmonary disease requiring oxygen)
  • Currently is enrolled in another diabetes management intervention study

Age

  • Originally was diagnosed with type 2 diabetes before the age of 21 years

Other

  • Is currently prescribed insulin
  • Currently is using a CGM device
  • Is pregnant or planning to become pregnant within the next 6 months
  • Has other concerns that may interfere significantly with their ability to participate in the intervention (ongoing health issues, personal events, etc.)

Who the study is looking for

  • Received outpatient care in the participating health system in the last 12 months
  • Has a diagnosis of type 2 diabetes mellitus (ICD10 codes E08.xx, E09.xx, E11.xx, E13.xx,O24.1x , O24.3x, O24.8x, O24.9x)
  • Last Hemoglobin A1c (HbA1c) value obtained in the last 6 months was ≥7.5%
  • Currently prescribed at least one non-insulin diabetes medication
  • Able to provide informed consent
  • Able to interact with a simple smartphone application
  • Owns or has access to a smartphone that is able to access an internet website
  • Did not participate a prior study related to this protocol

Age in the registry: 25 years to 75 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Pittsburgh
Coordinator of this site? Confirm its status
PittsburghUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.